Combination of low body mass index and serum albumin level is associated with chronic kidney disease progression: the chronic kidney disease-research of outcomes in treatment and epidemiology (CKD-ROUTE) study

Combination of low body mass index and serum albumin level is associated with chronic kidney disease progression: the chronic kidney disease-research of outcomes in treatment and epidemiology (CKD-ROUTE) study
复制标题

DOI:
10.1007/s10157-016-1251-2
复制
发表时间:
2017-02-01
影响因子:
2.3
通讯作者:
Uchida, Shinichi
Uchida, Shinichi
中科院分区:
医学4区
文献类型:
--
作者:
Kikuchi, Hiroaki;Kanda, Eiichiro;Uchida, Shinichi

文献摘要

被引文献

相似文献

蛋白质-能量消耗与慢性肾脏病(CKD)进展之间的关系尚不清楚。在目前的前瞻性队列研究中,我们评估的假设,低体重指数(BMI)和血清白蛋白水平的组合与快速CKD progress.Methods的研究队列包括728例透析前日本CKD患者(阶段2-5)从2010年至2011年入组。根据血清白蛋白水平和BMI将患者分为4组:第1组,低血清白蛋白水平(= 23.5 kg/m2);第4组,高血清白蛋白水平和高BMI。主要结局是估计肾小球滤过率(eGFR)下降30%或2年内开始透析。次要结果是每年GFR下降(mL/min/1.73 m2/year)。结果根据基线特征(参考,第4组)调整的Logistic回归分析显示,只有第1组与CKD进展的显著风险相关,调整后的比值比为3.51 [95%置信区间(CI)(1.63,7.56)]。校正基线特征后的多元线性回归分析显示,第1组和第4组之间的eGFR年下降率存在显著差异[系数β(标准误)-2.62(0.75),p = 0.001]。
Background The relationship between protein-energy wasting and chronic kidney disease (CKD) progression is unknown. In the present prospective cohort study, we evaluated the hypothesis that a combination of low body mass index (BMI) and serum albumin level is associated with rapid CKD progression.Methods The study cohort comprised 728 predialysis Japanese patients with CKD (stages 2-5) enrolled from 2010 to 2011. Patients were categorized into four groups according to their serum albumin levels and BMI: group 1, low serum albumin level (= 23.5 kg/m(2)); and group 4, high serum albumin level and high BMI. The primary outcome was a 30 % decline in estimated glomerular filtration rate (eGFR) or start of dialysis within 2 years. The secondary outcome was an annual GFR decline (mL/min/1.73 m(2)/year).Results Logistic regression analysis adjusted for baseline characteristics (reference, group 4) showed that only group 1 was associated with a significant risk of CKD progression, with adjusted odds ratio of 3.51 [95 % confidence interval (CI) (1.63, 7.56)]. A multivariate linear regression analysis adjusted for baseline characteristics showed a significant difference in annual eGFR decline between groups 1 and 4 [coefficients beta (standard error) -2.62 (0.75), p = 0.001].Conclusion This study suggests that combined effects of low BMI (